Yang Deng
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Dermatology top 5%
- Skin Protection and Aging
Papers in
-
- RNA Interference and Gene Delivery 2
-
- Advancements in Transdermal Drug Delivery 3
- Advanced Drug Delivery Systems 3
- Co-authors
- W. Mark Saltzman (5 shared papers)Fan Yang (2 shared papers)Michael Girardi (2 shared papers)Asiri Ediriwickrema (1 shared paper)Julia M. Lewis (1 shared paper)Eric Song (3 shared papers)Meiying Wu (5 shared papers)Jiajia Cui (2 shared papers)
- Journals
- Biomaterials (2 papers)BMC Public Health (2 papers)Journal of the American Chemical Society (2 papers)Nature Communications (2 papers)International Journal of Pharmaceutics (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yang Deng
35 papers receiving 870 citations
Peers
Comparison fields: 5 of 118
- Pharmaceutical Science 112
- Dermatology 124
- Biomaterials 183
- Biomedical Engineering 252
- Rehabilitation 25
Countries citing papers authored by Yang Deng
This map shows the geographic impact of Yang Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Deng more than expected).
Fields of papers citing papers by Yang Deng
This network shows the impact of papers produced by Yang Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Deng. The network helps show where Yang Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 186 | |
| 2 | 2017 | 83 | |
| 3 | 2008 | 71 | |
| 4 | 2016 | 67 | |
| 5 | 2023 | 60 | |
| 6 | 2022 | 58 | |
| 7 | 2017 | 56 | |
| 8 | 2020 | 37 | |
| 9 | 2022 | 34 | |
| 10 | 2022 | 32 | |
| 11 | 2024 | 30 | |
| 12 | 2022 | 26 | |
| 13 | 2021 | 17 | |
| 14 | 2023 | 12 | |
| 15 | 2021 | 10 | |
| 16 | 2024 | 10 | |
| 17 | 2022 | 9 | |
| 18 | 2022 | 9 | |
| 19 | 2023 | 7 | |
| 20 | 2024 | 7 |
About Yang Deng
Yang Deng is a scholar working on Molecular Biology, Pharmaceutical Science, Infectious Diseases, Oncology and Epidemiology, having authored 35 papers that have together received 879 indexed citations. Recurring topics across this work include COVID-19 epidemiological studies (4 papers), Nanoparticle-Based Drug Delivery (4 papers), HIV/AIDS Research and Interventions (3 papers), Advancements in Transdermal Drug Delivery (3 papers), Advanced Drug Delivery Systems (3 papers), Nanoplatforms for cancer theranostics (3 papers), RNA Interference and Gene Delivery (2 papers) and COVID-19 and Mental Health (2 papers). The work is most often cited by research in Pharmaceutical Science (112 citations), Dermatology (124 citations), Biomaterials (183 citations), Biomedical Engineering (252 citations) and Rehabilitation (25 citations). Yang Deng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include W. Mark Saltzman, Fan Yang, Michael Girardi, Asiri Ediriwickrema, Julia M. Lewis, Eric Song, Meiying Wu, Jiajia Cui, Tianqi Wang and Mian Yu. Their work appears in journals such as Biomaterials, BMC Public Health, Journal of the American Chemical Society, Nature Communications and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.